Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
america
billy dunn
biogen
biotech
chronic pain
clinical trials
drug prices
drug pricing
europe
europe top stories
evrysdi
fda
gene therapy
genentech
health
ionis pharmaceuticals
khosla ventures
life sciences
medicine
national
national blog main
national top stories
new york
new york top stories
novartis
nusinersen
pain
physical therapy
risdiplam
rna drugs
roche
san francisco
san francisco top stories
spinal muscular atrophy
spinraza
tc
united states
wearable devices
zolgensma
What
muscular
2
×
new
therapy
2
×
ago
approved
atrophy
based
billion
company
costs
daily
disorders
drug
europe
evrysdi
fda
financing
founded
friday
green
health
healthcare
home
intended
khosla
lights
liquid
market
medicine
million
oral
patients
physical
prescribed
raised
raises
risdiplam
roche
roughly
round
Language
unset
Current search:
muscular
×
therapy
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures
